Particle.news
Download on the App Store

Microgravity on the ISS Yields Phage Variants That Hit Drug‑Resistant E. coli

Researchers say microgravity reshapes phage–bacteria evolution, yielding receptor variants with improved activity against certain drug‑resistant E. coli on Earth.

Overview

  • Parallel infections on the International Space Station and on Earth showed an initial delay in phage activity in microgravity before T7 phages eventually propagated and reduced E. coli populations.
  • Whole-genome sequencing revealed distinct mutation patterns in both the T7 phage and E. coli in space compared with ground controls.
  • Deep mutational scanning identified microgravity-associated changes in the phage receptor binding protein that affect how the virus recognizes and binds host cells.
  • Follow-up experiments under normal gravity linked these receptor variants to increased activity against some T7-resistant, drug-resistant E. coli strains that cause urinary tract infections.
  • Led by University of Wisconsin–Madison with Rhodium Scientific, the peer-reviewed study in PLOS Biology points to space-driven selection as a potential guide for engineering improved therapeutic phages.